Evidence map›Paper›PMID 41621880›Full record

ArticleInternal medicine (Tokyo, Japan)2026

Gastric Epithelial Neoplasms with Fundic Gland Mucosa Lineage - Size and Morphology Correlate Well with Tumor Depth.

Kyoichi Adachi, Utae Sakamoto, Eiko Okimoto, Yuko Matsubara, Manabu Yoshida, Hiroshi Miura, Norihisa Ishimura, Shunji Ishihara

Abstract read
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kyoichi AdachiHealth Center, Shimane Environment and Health Public, Japan.
Utae SakamotoHealth Center, Shimane Environment and Health Public, Japan.
Eiko OkimotoHealth Center, Shimane Environment and Health Public, Japan.
Yuko MatsubaraHealth Center, Shimane Environment and Health Public, Japan.
Manabu YoshidaDepartment of Pathology, Matsue Municipal Hospital, Japan.
Hiroshi MiuraDepartment of Pathology, Matsue Red Cross Hospital, Japan.
Norihisa IshimuraSecond Department of Internal Medicine, Shimane University Faculty of Medicine, Japan.
Shunji IshiharaSecond Department of Internal Medicine, Shimane University Faculty of Medicine, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective Gastric adenocarcinoma of the fundic gland type (GA-FG) without submucosal invasion is classified as an oxyntic gland adenoma (OGA). This study aimed to investigate differences in characteristics between OGAs and GA-FGs with submucosal invasion. Methods A retrospective analysis of 15 OGAs and 14 GA-FGs diagnosed between April 2016 and March 2025 was conducted. Patient clinical characteristics as well as tumor size, location, and endoscopic features (shape, surface redness, dilated vessels on surface) were compared between the two groups. Results There were no significant differences regarding patient sex, age, or Helicobacter pylori infection status. OGAs were significantly smaller than GA-FGs. Additionally, flat type and the absence of dilated vessels were identified as characteristic endoscopic features of OGAs. Location and surface redness did not differ between these two types. Conclusion Among gastric fundic gland type tumors, OGAs are characterized by small size, flat morphology, and the absence of dilated vessels.

Indexed as

AdenocarcinomaAdenomaGastric FundusGastric MucosaStomach NeoplasmsAgedFemaleGastroscopyHumansMaleMiddle AgedRetrospective Studiesendoscopygastric adenocarcinoma of the fundic gland typegastric canceroxyntic gland adenomasize

Identifiers

PMID41621880
PMCPMC13668782

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.